Walvax Biotechnology Market Cap

Walvax Biotechnology has a market cap or net worth of 18.73 billion as of December 5, 2025. Its market cap has decreased by -28.16% in one year.

Market Cap

18.73B

Enterprise Value

18.58B

Revenue

2.40B

Ranking

n/a

PE Ratio

380.31

Stock Price

11.71

Market Cap Chart

Since November 12, 2010, Walvax Biotechnology's market cap has increased from 13.63B to 18.73B, an increase of 37.36%. That is a compound annual growth rate of 2.13%.

Market Cap History

Date	Market Cap	% Change
Dec 5, 2025	18.73B	-3.06%
Dec 31, 2024	19.32B	-48.62%
Dec 29, 2023	37.60B	-41.50%
Dec 30, 2022	64.27B	-28.12%
Dec 31, 2021	89.42B	50.25%
Dec 31, 2020	59.52B	19.33%
Dec 31, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Jiangsu Hengrui Pharmaceuticals Co.,Ltd	407.00B
WuXi AppTec	267.37B
Shenzhen Mindray Bio-Medical Electronics	241.88B
Sichuan Biokin Pharmaceutical	150.71B
Shanghai United Imaging Healthcare	105.68B
Aier Eye Hospital Group	104.39B
Zhangzhou Pientzehuang Pharmaceutical.,	101.81B
Yunnan Baiyao Group Co.,Ltd	99.40B

Market Cap Rankings